Literature DB >> 8641599

Subcutaneous fluids in elderly hospital patients with cognitive impairment.

S T O'Keeffe1, J N Lavan.   

Abstract

Sixty patients (mean age 80 years) with cognitive impairment who required parenteral fluids for at least 48 h were randomized to receive either intravenous (i.v.) or subcutaneous (s.c.) fluids. There was no significant difference in the mean volume of fluid prescribed over 48 h in the two groups (s.c. 3.3 litres vs. i.v. 3.6 litres) or in the proportion of prescribed fluids actually administered (s.c. 0.82 vs. i.v. 0.76). After adjusting for baseline differences, there was no difference between serum urea or creatinine levels in the two groups at 48 h. Agitation related to the infusion was reported in 11 (37%) patients receiving s.c. fluids and 24 (80%) patients receiving i.v. fluids (p < 0.005). The cost of the cannulae used during the study was 6.80 pounds for the s.c. group and 28.70 pounds for the i.v. group. Local oedema was noted in 2 patients in the s.c. group and led to re-siting of the infusion in 1 patient. No other complication was noted. These results suggest that s.c. fluid therapy is the treatment of choice in nonurgent situations for confused patients who require parenteral fluids.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641599     DOI: 10.1159/000213768

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  7 in total

1.  [Subcutaneous infusions for geriatric patients: rediscovery of an "old" technique].

Authors:  A H Leischker
Journal:  Z Gerontol Geriatr       Date:  2012-10       Impact factor: 1.281

Review 2.  Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease.

Authors:  Katharine Ker; Gavin Tansley; Deirdre Beecher; Anders Perner; Haleema Shakur; Tim Harris; Ian Roberts
Journal:  Cochrane Database Syst Rev       Date:  2015-02-26

3.  [Medication in the elderly : cognitive impairment by drugs].

Authors:  M Wehling
Journal:  Internist (Berl)       Date:  2012-10       Impact factor: 0.743

4.  Comparison of the tolerability of recombinant human hyaluronidase + normal saline and recombinant human hyaluronidase + lactated ringer's solution administered subcutaneously: A phase IV, double-blind, randomized pilot study in healthy volunteers.

Authors:  Samuel S Dychter; David Ebel; Tonya R Mead; Richard C Yocum
Journal:  Curr Ther Res Clin Exp       Date:  2009-12

5.  Subcutaneous dextrose for rehydration of elderly patients--an evidence-based review.

Authors:  Tari Turner; Anne-Marie Cassano
Journal:  BMC Geriatr       Date:  2004-04-15       Impact factor: 3.921

6.  Pilot study on the effect of subcutaneous administration of lactated Ringer's solution on biochemistry parameters in healthy euvolemic cats.

Authors:  M Ryan Smith; Rebecca J Greer
Journal:  Vet Med Sci       Date:  2016-01-18

Review 7.  Management of Dehydration in Patients Suffering Swallowing Difficulties.

Authors:  Emilie Reber; Filomena Gomes; Ilka A Dähn; Maria F Vasiloglou; Zeno Stanga
Journal:  J Clin Med       Date:  2019-11-08       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.